| Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease L Jostins, S Ripke, RK Weersma, RH Duerr, DP McGovern, KY Hui, ... Nature 491 (7422), 119-124, 2012 | 5445 | 2012 |
| Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci A Franke, DPB McGovern, JC Barrett, K Wang, GL Radford-Smith, ... Nature genetics 42 (12), 1118-1125, 2010 | 3237 | 2010 |
| Erratum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (Nature Genetics (2011) 43 (246-252)) CA Anderson, G Boucher, CW Lees, A Franke, M D'Amato, KD Taylor, ... Nature Genetics 43 (9), 2011 | 1772 | 2011 |
| Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study I Cleynen, G Boucher, L Jostins, LP Schumm, S Zeissig, T Ahmad, ... The Lancet 387 (10014), 156-167, 2016 | 893 | 2016 |
| Intestinal barrier dysfunction in inflammatory bowel diseases MA McGuckin, R Eri, LA Simms, THJ Florin, G Radford-Smith Inflammatory bowel diseases 15 (1), 100-113, 2009 | 790 | 2009 |
| Crohn's disease management after intestinal resection: a randomised trial P De Cruz, MA Kamm, AL Hamilton, KJ Ritchie, EO Krejany, A Gorelik, ... The Lancet 385 (9976), 1406-1417, 2015 | 663 | 2015 |
| International IBD Genetics Consortium (IIBDGC)(2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease L Jostins, S Ripke, RK Weersma, RH Duerr, DP McGovern, KY Hui, ... Nature 491 (7422), 119-124, 2012 | 647 | 2012 |
| Morphology of sporadic colorectal cancer with DNA replication errors JR Jass, KA Do, LA Simms, H Iino, C Wynter, SP Pillay, J Searle, ... Gut 42 (5), 673-679, 1998 | 579 | 1998 |
| Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s disease W Selby, P Pavli, B Crotty, T Florin, G Radford-Smith, P Gibson, B Mitchell, ... Gastroenterology 132 (7), 2313-2319, 2007 | 483 | 2007 |
| Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus A Bourreille, A Ignjatovic, L Aabakken, EV Loftus Jr, R Eliakim, ... | 384 | 2009 |
| Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature NA Koloski, L Bret, G Radford-Smith World journal of gastroenterology: WJG 14 (2), 165, 2008 | 375 | 2008 |
| Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection M Julsgaard, LA Christensen, PR Gibson, RB Gearry, J Fallingborg, ... Gastroenterology 151 (1), 110-119, 2016 | 374 | 2016 |
| Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection M Regueiro, BG Feagan, B Zou, J Johanns, MA Blank, M Chevrier, ... Gastroenterology 150 (7), 1568-1578, 2016 | 345 | 2016 |
| Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery EK Wright, MA Kamm, P De Cruz, AL Hamilton, KJ Ritchie, EO Krejany, ... Gastroenterology 148 (5), 938-947. e1, 2015 | 341 | 2015 |
| Role of diet in the development of inflammatory bowel disease CA Chapman-Kiddell, PSW Davies, L Gillen, GL Radford-Smith Inflammatory bowel diseases 16 (1), 137-151, 2010 | 330 | 2010 |
| Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn’s disease LA Simms, JD Doecke, MD Walsh, N Huang, EV Fowler, ... Gut 57 (7), 903-910, 2008 | 321 | 2008 |
| Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn’s disease GL Radford-Smith, JE Edwards, DM Purdie, N Pandeya, M Watson, ... Gut 51 (6), 808-813, 2002 | 311 | 2002 |
| consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017 | 286 | 2017 |
| Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression JE Craig, X Han, A Qassim, M Hassall, JNC Bailey, TG Kinzy, AP Khawaja, ... Nature genetics 52 (2), 160-166, 2020 | 270 | 2020 |
| Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma MH Law, DT Bishop, JE Lee, M Brossard, NG Martin, EK Moses, F Song, ... Nature genetics 47 (9), 987, 2015 | 259 | 2015 |
